Mitchell H. Finer, PhD

Senior Scientific Advisor

Dr. Finer is a Senior Scientific Advisor for AlloVir.

Dr. Mitchell Finer has been instrumental in founding, building and leading a number of MPM portfolio companies. For three decades, he has focused on drug development utilizing the novel platforms of cell and gene therapy, cancer immunotherapy and regenerative medicine. Dr. Finer is currently Chief Scientific Officer of ElevateBio and President of ElevateBio BaseCamp.

Prior to ElevateBio, Mitch founded and is the former CEO of Oncorus, focused on the development of oncolytic herpes viruses for the treatment of solid tumors. He is also a founder and the former CEO of CODA Biotherapeutics, focused on developing achemogenetic neuromodulation platform for the treatment of severe neurological disorders. Mitch serves on several MPM portfolio company boards, includingCODA, Oncorus, Semma Therapeutics and TCR2 Therapeutics.

Prior to joining MPM, he was the CSO of bluebird bio. He has also served as CEO of Intracel Corporation and Genteric, Vice President Research for Cell Genesys and the Gencell division of Aventis Pharma (now Sanofi) and Senior Vice President of Development at Novacell (now Viacyte). He also successfully co-founded a retinal disease gene therapy company Avalanche Biotechnologies (now Adverum Biotechnologies) where he serves as a member of the board of directors.

Mitch has been named inventor on 15 issued U.S. patents. He received his Ph.D. in Biochemistry and Molecular Biology from Harvard University and a B.S. in Biochemistry and Microbiology from the University of California at Berkeley. He completed a post-doctoral fellowship at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology.

Life @ AlloVir

Mission-driven teams developing transformative cell therapies for patients deserve transformative benefits. We make sure your life outside the lab is as purposeful as your life inside it.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
PTO Policies
Making sure that you have the freedom to time off when you need to is an important part of our culture. Life beyond the lab includes a flexible approach to PTO; you take it when you need it.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
401k Plans
We offer 401(k) matching, employer-paid life short and long-term disability, and life insurance.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
Healthcare
Our health plans include medical, vision, and dental covered at 90%, as well as Flexible Spending Accounts (FSA) and Dependent Care Accounts (DCA).
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
Family Leave
Growing and taking care of your family is as important as the work you do. We offer a generous parental leave program that allows you to do just that.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
Cell phone and commuter reimbursement
Being connected and getting where you need to go is an important part of your work. We offer cell phone and commuter reimbursement programs that acknowledge the time you spend in and out of the office.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now

AlloVir is the Global Leader in Developing VST Immunotherapies

We develop highly innovative allogeneic, off-the-shelf VST therapy candidates designed to treat or prevent devastating viral infections and diseases.

Our Pipeline

Our allogeneic, off-the-shelf, VST therapy candidates target 12 different devastating viruses to treat or prevent life-threatening viral diseases.
view

Our Platform

Our proprietary platform develops allogeneic, off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies.
learn

Our People

Our founders have a singular vision: to serve patients at risk of the devastating consequences of severe viral infections and diseases.
meet